Working Hours
Mon - Sat 9:00 - 6:00


Price:
Price 40.0 INR / Box
Minimum Order Quantity : 50 Boxes
Physical Form : Liquid
Quantity : 50 Boxes
Drug Type : Injection
Ingredients : Product Title: NEOCURON Injection 4 mg/2 ml (Pancuronium Bromide Injection) Category Medical Equipment & Supplies Pharmaceutical Drugs Injectable Medicines Product Description: Neocuron Injection 4 mg/2 ml contains Pancuronium Bromide, a longacting nondepolarizing neuromuscular blocking agent used in anaesthesia to facilitate muscle relaxation during surgical procedures. It works by blocking neuromuscular transmission, resulting in skeletal muscle relaxation, which is essential for procedures such as endotracheal intubation and controlled ventilation. This injection is widely used in operation theatres and intensive care units under strict medical supervision. Key Features: Composition: Pancuronium Bromide 4 mg / 2 ml Dosage Form: Injection Pack Size: 2 ml ampoule/vial Route of Administration: Intravenous (IV) Longacting muscle relaxant Applications: Muscle relaxation during surgery Facilitation of endotracheal intubation Controlled ventilation in ICU Anaesthesia adjunct in surgical procedures Benefits: Provides sustained muscle relaxation Improves surgical conditions Supports safe and effective ventilation Widely used in anaesthesia practice Storage Instructions: Store in a cool and dry place Protect from light Keep in original packaging Safety Information: For hospital use only To be administered by trained anaesthetists Requires ventilatory support and monitoring Use strictly as per prescription Additional Information: Pancuronium Bromide is a wellestablished neuromuscular blocking agent used in modern anaesthesia for achieving controlled muscle paralysis during surgical and critical care procedures.
Price 43.0 INR / Unit
Minimum Order Quantity : 50 Units
Physical Form : Tablets
Quantity : 10x10 Tablets Unit
Drug Type : Other
Ingredients : Ondansetron Hydrochloride
Price 3500.0 INR / Vial
Minimum Order Quantity : 5 Units
Physical Form : Powder
Quantity : 1 Unit
Drug Type : Injection
Ingredients : Bevacizumab (often sold under brand names like Avastin) is a targeted cancer therapy injection. A Bevacizab 100 mg injection usually contains 100 mg of bevacizumab in a vial for intravenous infusion. What it is used for Doctors prescribe bevacizumab for several cancers, including: Colorectal Cancer Non Small Cell Lung Cancer Glioblastoma Kidney Cancer Cervical Cancer Ovarian Cancer How it works Bevacizumab blocks Vascular Endothelial Growth Factor (VEGF), a protein that tumors use to create new blood vessels. By blocking VEGF, the drug reduces blood supply to tumors, slowing their growth. How it is given Administered by IV infusion (into a vein) in a hospital or oncology clinic. Dose depends on body weight and cancer type. Usually given every 2 3 weeks with chemotherapy or other treatments. Possible side effects Common: High blood pressure Nosebleeds Fatigue Headache Serious (need medical attention): Bleeding problems Poor wound healing Blood clots Kidney problems (protein in urine) Important precautions Should only be given under an oncologist s supervision. Not recommended during pregnancy. Surgery patients often stop the drug weeks before/after surgery because it affects healing. About the 100 mg vial: The 100 mg strength is typically used to prepare the required dose for infusion; multiple vials may be combined depending on the patient s weight.
Price 7150.0 INR / Vial
Minimum Order Quantity : 5 Vials
Physical Form : Powder
Quantity : 1 Unit
Drug Type : Injection
Ingredients : Bevacizab 400 mg injection contains the medicine Bevacizumab, which is an anticancer (monoclonal antibody) drug used in oncology treatment. What Bevacizab (Bevacizumab) is used for Doctors use it to treat several cancers, usually together with chemotherapy, such as: Colon / rectal cancer Lung cancer (nonsmall cell lung cancer) Breast cancer Kidney cancer Ovarian cancer Cervical cancer Brain tumors (glioblastoma) How it works Bevacizumab blocks a protein called VEGF (vascular endothelial growth factor). Tumors need new blood vessels to grow. This injection stops new blood vessel formation, reducing the supply of oxygen and nutrients to the tumor. As a result, tumor growth slows or stops. How it is given Given intravenously (IV infusion) in a hospital. Must be administered by oncology doctors or nurses. Dose and schedule depend on body weight and cancer type. Common side effects Nausea or vomiting Weakness or fatigue Diarrhea Nosebleeds Loss of appetite High blood pressure Must be stopped before and after major surgery because it can delay wound healing. Only used with doctor s prescription and monitoring
